37,905 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by Yelin Lapidot Holdings Management Ltd. etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Yelin Lapidot Holdings Management Ltd. Invests $1.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported preliminary, unaudited fourth quarter and full year 2023 net product revenue.
PLYMOUTH MEETING, Pa., Jan. 3, 2024 /PRNewswire/ Harmony Biosciences Holdings, Inc. , a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with.
Harmony Biosciences: 4 Problems With Investing (Rating Downgrade) (NASDAQ:HRMY) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.